Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) FCF Margin (2023 - 2024)

Praxis Precision Medicines has reported FCF Margin over the past 2 years, most recently at 752.0% for Q4 2024.

  • Quarterly results put FCF Margin at 752.0% for Q4 2024, up 388120.0% from a year ago — trailing twelve months through Sep 2025 was 3067.41% (up 313172.0% YoY), and the annual figure for FY2024 was 1540.48%, up 300329.0%.
  • FCF Margin for Q4 2024 was 752.0% at Praxis Precision Medicines, up from 9105.96% in the prior quarter.
  • Over the last five years, FCF Margin for PRAX hit a ceiling of 752.0% in Q4 2024 and a floor of 9105.96% in Q3 2024.